preliminary results. Corporate leadership Flemming Ørnskov, was the company's chief executive officer through 8 January 2019 with Takeda's acquisition of Shire. Ginger Gregory as chief human resources officer, Jeffrey Poulton as CFO, and Philip Vickers as head of R&D. James Bowling vacated his position as interim CFO in the aftermath of the collapse of the AbbVie inversion deal. The chair of Shire's board of directors was Susan Kilsby. Legal issues False Claims Act violations In September 2014, Shire reached a $56.5 million settlement with the U.S. Department of Justice for alleged violations of the False Claims Act. The Justice Department alleged that Shire had improperly marketed and promoted Adderall XR, Daytrana, Vyvane, Pentasa, and Lialda during various periods between 2004 and 2010. The allegations included claims that Shire had made exaggerated and false statements regarding product safety, promoted medications for non-FDA approved off-label use, and marketed products on unsubstantiated claims of beneficial side effects, including reductions in criminality, traffic accidents, sexually transmitted infections, and divorce rates. Illegal promotion of Dermagraft In August 2017, Shire reached a $350 million settlement with the Department of Justice for violations of the same act, regarding the unlawful promotion of Shire's product Dermagraft. See also Pharmaceutical industry in the United Kingdom Takeda Pharmaceuticals References External links Pharmaceutical companies established in 1986 Pharmaceutical companies disestablished in 2019 Pharmaceutical companies of Ireland Pharmaceutical companies of the United Kingdom Biotechnology companies of Ireland Biotechnology companies of the United Kingdom Biotechnology companies established in 1986 Biotechnology companies disestablished in 2019 Defunct companies of Jersey Companies based in Dublin (city) Companies based in Basingstoke Companies formerly listed on the London Stock Exchange Companies formerly listed on the Nasdaq Multinational companies headquartered in the Republic of Ireland Irish companies established in 1986 2019 disestablishments in Ireland 1986 establishments in Jersey 2019 disestablishments in Jersey Orphan drug companies Life sciences industry British companies established in 1986 British companies disestablished in 2019 2019 mergers and acquisitions Takeda Pharmaceutical Company Tax inversions